Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
US Army
US Department of Justice
Express Scripts
Chinese Patent Office
Covington
Boehringer Ingelheim
Accenture
Deloitte

Generated: June 20, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Matrix Labs

« Back to Dashboard

Matrix Labs Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Matrix Labs lamivudine 078545 150MG TABLET; ORAL
Matrix Labs lamivudine; zidovudine 079079 150MG; 300MG TABLET; ORAL
Matrix Labs lamivudine; tenofovir disoproxil fumarate 022141 300MG; 300MG TABLET; ORAL
Matrix Labs Ltd lopinavir; ritonavir 079074 200MG; 50MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Citi
Deloitte
Chinese Patent Office
Colorcon
Express Scripts
US Army
Chubb
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.